Hudson Capital Management LLC

Position in NVS — Novartis AG

CIK 1727342 RAMSEY, NJ

Position in NVS

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$319,708

+$8,098 QoQ

Shares Held

2,040

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,097

of 1,603 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Hudson Capital Management LLC holds $13,852,767 across 5 Drug Manufacturers - General names. NVS ranks #3 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	52,947	$6,689,323
2	BMY	Bristol Myers Squibb Co	109,354	$6,300,977
3	NVS	Novartis AG This page	2,040	$319,708
4	MRK	Merck & Co., Inc.	2,196	$282,186
5	JNJ	Johnson & Johnson	1,026	$260,573

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$319,708	2,040	0.0%	Shares	Sole	2026-07-14
2026-03-31	$311,610	2,040	0.0%	Shares	Sole	2026-04-13
2025-12-31	$281,254	2,040	-0.4%	Shares	Sole	2026-01-21
2025-09-30	$262,635	2,048	0.0%	Shares	Sole	2025-10-21
2025-06-30	$247,828	2,048	—	Shares	Sole	2025-07-28
No filing history on record for this holder in this stock.